Blockchain Registration Transaction Record

Aclarion Adds First Private Practice Site to CLARITY Trial

Aclarion adds Lanman Spinal Neurosurgery as first private practice site in CLARITY trial for Nociscan, a noninvasive AI platform that identifies pain-generating discs to improve chronic low back pain outcomes.

This news matters because chronic low back pain affects millions worldwide, and current diagnostic tools often fail to identify the exact source of pain, leading to unnecessary surgeries or ineffective treatments. Nociscan’s AI-driven approach could revolutionize patient care by ensuring that only the pain-generating discs are treated, potentially reducing failed back surgery syndrome and improving outcomes. The inclusion of a leading private practice like Lanman Spinal Neurosurgery signals growing clinical adoption, bringing this technology closer to everyday use. For patients, this means more precise diagnoses and tailored treatments; for healthcare providers, it offers a data-driven tool to enhance decision-making and surgical success rates. The CLARITY trial’s results could set a new standard in spine care, making this a pivotal development in pain management.